TRICCAR, Inc. TCCR OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

15/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

TRICCAR, Inc. (TCCR) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 14/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

15/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

15/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — TCCR

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio1,327.18

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2012	$-1.83	$21.71M	$-6.05M	-27.9%
2013	$-1.66	$30.21M	$-8.74M	-28.9%
2014	$-0.92	$16.08M	$-5.29M	-32.9%
2015	$-0.68	$3.82M	$-6.03M	-157.9%
2016	$-0.15	$1.28M	$-1.79M	-139.8%
2017	$-0.11	$1.14M	$-1.39M	-121.9%
2018	$-0.06	$1.14M	$-886.3K	-78.1%
2019	$-0.29	$892.27K	$-4.15M	-465.6%
2020	$0.00	$0.00	$-106.18K	-
2021	$0.00	$98.45K	$-90.25K	-91.7%